P

Pulike Biological Engineering Inc
SSE:603566

Watchlist Manager
Pulike Biological Engineering Inc
SSE:603566
Watchlist
Price: 12.42 CNY -1.04% Market Closed
Market Cap: 4.3B CNY

Gross Margin
Pulike Biological Engineering Inc

60.5%
Current
62%
Average
48.9%
Industry

Gross Margin is the amount of money a company retains after incurring the direct costs associated with producing the goods it sells and the services it provides. The higher the gross margin, the more capital a company retains, which it can then use to pay other costs or satisfy debt obligations.

Gross Margin
60.5%
=
Gross Profit
656.4m
/
Revenue
1.1B

Gross Margin Across Competitors

Pulike Biological Engineering Inc
Glance View

Market Cap
4.3B CNY
Industry
Pharmaceuticals

Pulike Biological Engineering, Inc. engages in the research, development, manufacturing and sale of biological products for animals, chemical drugs and Chinese veterinary drugs. The company is headquartered in Luoyang, Henan and currently employs 1,809 full-time employees. The company went IPO on 2015-05-18. Inc is principally engaged in the research, development, production and distribution of veterinary biological products and chemical medicines. The firm's veterinary biological products include vaccine and antibody, applied in the prevention and controlling of infection to epidemic disease for poultry and livestock. Its veterinary chemical medicines are mainly used in the treatment of epidemic diseases of poultry and livestock.

Intrinsic Value
17.35 CNY
Undervaluation 28%
Intrinsic Value
Price
P
What is Gross Margin?

Gross Margin is the amount of money a company retains after incurring the direct costs associated with producing the goods it sells and the services it provides. The higher the gross margin, the more capital a company retains, which it can then use to pay other costs or satisfy debt obligations.

Gross Margin
60.5%
=
Gross Profit
656.4m
/
Revenue
1.1B
What is the Gross Margin of Pulike Biological Engineering Inc?

Based on Pulike Biological Engineering Inc's most recent financial statements, the company has Gross Margin of 60.5%.

Back to Top